Literature DB >> 26369828

The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method.

Vineet Chopra, Scott A Flanders, Sanjay Saint, Scott C Woller, Naomi P O'Grady, Nasia Safdar, Scott O Trerotola, Rajiv Saran, Nancy Moureau, Stephen Wiseman, Mauro Pittiruti, Elie A Akl, Agnes Y Lee, Anthony Courey, Lakshmi Swaminathan, Jack LeDonne, Carol Becker, Sarah L Krein, Steven J Bernstein.   

Abstract

Use of peripherally inserted central catheters (PICCs) has grown substantially in recent years. Increasing use has led to the realization that PICCs are associated with important complications, including thrombosis and infection. Moreover, some PICCs may not be placed for clinically valid reasons. Defining appropriate indications for insertion, maintenance, and care of PICCs is thus important for patient safety. An international panel was convened that applied the RAND/UCLA Appropriateness Method to develop criteria for use of PICCs. After systematic reviews of the literature, scenarios related to PICC use, care, and maintenance were developed according to patient population (for example, general hospitalized, critically ill, cancer, kidney disease), indication for insertion (infusion of peripherally compatible infusates vs. vesicants), and duration of use (≤5 days, 6 to 14 days, 15 to 30 days, or ≥31 days). Within each scenario, appropriateness of PICC use was compared with that of other venous access devices. After review of 665 scenarios, 253 (38%) were rated as appropriate, 124 (19%) as neutral/uncertain, and 288 (43%) as inappropriate. For peripherally compatible infusions, PICC use was rated as inappropriate when the proposed duration of use was 5 or fewer days. Midline catheters and ultrasonography-guided peripheral intravenous catheters were preferred to PICCs for use between 6 and 14 days. In critically ill patients, nontunneled central venous catheters were preferred over PICCs when 14 or fewer days of use were likely. In patients with cancer, PICCs were rated as appropriate for irritant or vesicant infusion, regardless of duration. The panel of experts used a validated method to develop appropriate indications for PICC use across patient populations. These criteria can be used to improve care, inform quality improvement efforts, and advance the safety of medical patients.

Entities:  

Mesh:

Year:  2015        PMID: 26369828     DOI: 10.7326/M15-0744

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  64 in total

1.  Persistent Barriers to Timely Catheter Removal Identified from Clinical Observations and Interviews.

Authors:  Martha Quinn; Jessica M Ameling; Jane Forman; Sarah L Krein; Milisa Manojlovich; Karen E Fowler; Elizabeth A King; Jennifer Meddings
Journal:  Jt Comm J Qual Patient Saf       Date:  2019-12-23

Review 2.  Tunneled and routine peripherally inserted central catheters placement in adult and pediatric population: review, technical feasibility, and troubleshooting.

Authors:  Nishant Gupta; Darshan Gandhi; Salil Sharma; Pradeep Goyal; Gagandeep Choudhary; Shuo Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

3.  The Italian Society of Internal Medicine choosing wisely campaign.

Authors:  Nicola Montano; Giorgio Costantino; Giovanni Casazza; Rodolfo Sbrojavacca; Marco Vincenzo Lenti; Lorenzo Falsetti; Annasanta Guzzo; Raffaele Majo; Francesco Perticone; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2016-11-01       Impact factor: 3.397

4.  Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physicians.

Authors:  N LeVasseur; C Stober; K Daigle; A Robinson; S McDiarmid; S Mazzarello; B Hutton; A Joy; D Fergusson; J Hilton; M McInnes; M Clemons
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

5.  Development and Implementation of a Bedside Peripherally Inserted Central Catheter Service in a PICU.

Authors:  Thomas W Conlon; Adam S Himebauch; Anne Marie Cahill; Blair M Kraus; Chinonyerem R Madu; Mark D Weber; Carol A Czajka; Ruby L Baker; Torron M Brinkley; Melanie D Washington; Anne Marie Frey; Eileen M Nelson; Cara T Jefferies; Charlotte Z Woods-Hill; Heather A Wolfe; Daniela H Davis
Journal:  Pediatr Crit Care Med       Date:  2019-01       Impact factor: 3.624

6.  Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System.

Authors:  Leland E Hull; Jason L Vassy; Annjanette Stone; Catherine C Chanfreau-Coffinier; Craig W Heise; Victoria M Pratt; Ronald Przygodzki; Corrine I Voils; Deepak Voora; Jessica Wang-Rodriguez; Steven A Schichman; Maren T Scheuner
Journal:  J Mol Diagn       Date:  2020-10       Impact factor: 5.568

Review 7.  Cardiorespiratory and Pulse Oximetry Monitoring in Hospitalized Children: A Delphi Process.

Authors:  Amanda C Schondelmeyer; Maya L Dewan; Patrick W Brady; Kristen M Timmons; Rhonda Cable; Maria T Britto; Christopher P Bonafide
Journal:  Pediatrics       Date:  2020-07-17       Impact factor: 7.124

Review 8.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

9.  Patterns and Predictors of Short-Term Peripherally Inserted Central Catheter Use: A Multicenter Prospective Cohort Study.

Authors:  David Paje; Anna Conlon; Scott Kaatz; Lakshmi Swaminathan; Tanya Boldenow; Steven J Bernstein; Scott A Flanders; Vineet Chopra
Journal:  J Hosp Med       Date:  2018-02       Impact factor: 2.960

10.  Peripherally Inserted Central Catheters and Hemodialysis Outcomes.

Authors:  Rita L McGill; Robin Ruthazer; Klemens B Meyer; Dana C Miskulin; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.